A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Phase 1/2 Recruiting
150 enrolled
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
155 enrolled
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Phase 3 Recruiting
2,130 enrolled
TRIDENT-1
Phase 1/2 Recruiting
500 enrolled 5 FDA
DP-04
Recruiting
100 enrolled
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Phase 2 Recruiting
60 enrolled
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Phase 2 Recruiting
44 enrolled
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Phase 2 Recruiting
37 enrolled
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
Phase 1/2 Recruiting
40 enrolled
DG-03
Phase 2 Recruiting
450 enrolled
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
Phase 1/2 Recruiting
51 enrolled
Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)
Phase 2 Recruiting
25 enrolled
ARBOR
Phase 1 Recruiting
37 enrolled
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
Phase 1/2 Recruiting
38 enrolled
GRACIE
Phase 2 Recruiting
88 enrolled
IPIZA
Phase 1/2 Recruiting
24 enrolled
Pan-tumor MRD Study
Recruiting
1,350 enrolled
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Phase 2 Recruiting
146 enrolled
Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer
Phase NA Recruiting
286 enrolled
SEQUEL
Phase 2 Recruiting
58 enrolled
JUMP
Phase NA Recruiting
86 enrolled
MEMENTO
Phase 2 Recruiting
14 enrolled
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
Phase 2 Recruiting
10 enrolled
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
Phase 2 Recruiting
37 enrolled
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Phase NA Recruiting
90 enrolled
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
Phase 2 Recruiting
46 enrolled
SERPAN
Recruiting
400 enrolled
SPACE
Recruiting
66 enrolled
BAH250
Phase 1/2 Recruiting
75 enrolled
LOGICAN
Phase 2 Recruiting
118 enrolled
HEPATOXALI
Phase NA Recruiting
100 enrolled
M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.
Phase 3 Recruiting
486 enrolled
Miracle-G
Phase 2 Recruiting
55 enrolled
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Phase 3 Recruiting
110 enrolled
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Phase 2 Recruiting
78 enrolled